ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable …,

The long-acting injectable regimen was preferred by majority of clinical trial patients who tried the treatment over their previous daily oral therapy., The long-acting injectable regimen was preferred by majority of clinical trial patients who tried the treatment over their previous daily oral therapy., Read More